Bone Loss Recruiting Phase 2 Trials for Lovastatin (DB00227)

Also known as: Osteopenia / Osteopaenia

IndicationStatusPhase
DBCOND0031952 (Bone Loss)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03981601Evaluation, the Histomorphometric Study of Nanocrystalline Hydroxyapatite (Nano Bone) Wif Lovastatin in the Preservation of the Tooth SocketTreatment